Modified Chickens May Offer Egg Drug Potential
From Times Wire Reports
A California biotechnology firm says it has developed a technique to genetically modify chickens to potentially produce drugs in their eggs for human diseases.
The technology, devised at the privately owned Origen Therapeutics and at UC Davis, lets scientists permanently alter the genetics of chicken eggs and sperm so the new traits are passed to succeeding generations, according to the report in this week’s issue of the journal Nature.
